Palo Alto Networks (PANW) 10-Q 17 Nov 23 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Oct. 31, 2023	Nov. 10, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-35594
Entity Registrant Name	PALO ALTO NETWORKS, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2530195
Entity Address, Address Line One	3000 Tannery Way
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	753-4000
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	PANW
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Small Business	false
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		315,300,000
Entity Central Index Key	0001327567
Document Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,491.4	$ 1,135.3
Short-term investments	1,402.4	1,254.7
Accounts receivable, net of allowance for credit losses of $8.2 and $7.8 as of October 31, 2023 and July 31, 2023, respectively	1,413	2,463.2
Short-term financing receivables, net	445.9	388.8
Short-term deferred contract costs	328.7	339.2
Prepaid expenses and other current assets	396.2	466.8
Total current assets	6,477.6	6,048
Property and equipment, net	352.6	354.5
Operating lease right-of-use assets	274.3	263.3
Long-term investments	2,988.9	3,047.9
Long-term financing receivables, net	639.8	653.3
Long-term deferred contract costs	515.4	547.1
Goodwill	2,926.8	2,926.8
Intangible assets, net	290.5	315.4
Other assets	342.6	344.8
Total assets	14,808.5	14,501.1
Current liabilities:
Accounts payable	131.8	132.3
Accrued compensation	331.4	548.3
Accrued and other liabilities	371.5	390.8
Deferred revenue	4,732	4,674.6
Convertible senior notes, net	1,946.7	1,991.5
Total current liabilities	7,513.4	7,737.5
Long-term deferred revenue	4,710.8	4,621.8
Long-term operating lease liabilities	275.8	279.2
Other long-term liabilities	138	114.2
Liabilities	12,638	12,752.7
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock; $0.0001 par value; 100.0 shares authorized; none issued and outstanding as of October 31, 2023 and July 31, 2023	0	0
Common stock and additional paid-in capital; $0.0001 par value; 1,000.0 shares authorized; 313.7 and 308.3 shares issued and outstanding as of October 31, 2023 and July 31, 2023, respectively	3,296.7	3,019
Accumulated other comprehensive loss	(93)	(43.2)
Accumulated deficit	(1,033.2)	(1,227.4)
Total stockholders’ equity	2,170.5	1,748.4
Total liabilities and stockholders’ equity	$ 14,808.5	$ 14,501.1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Current assets:
Allowance for doubtful accounts	$ 8.2	$ 7.8
Stockholders’ equity:
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	313,700,000	308,300,000
Common stock, shares outstanding (in shares)	313,700,000	308,300,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Revenue:
Revenue:	$ 1,878.1	$ 1,563.4
Cost of revenue:
Cost of revenue:	472.8	461.9
Total gross profit	1,405.3	1,101.5
Operating expenses:
Research and development	409.5	371.8
Sales and marketing	660.5	615
General and administrative	120.1	99.5
Total operating expenses	1,190.1	1,086.3
Operating income	215.2	15.2
Interest expense	(2.9)	(6.8)
Other income, net	70.3	26
Income before income taxes	282.6	34.4
Provision for income taxes	88.4	14.4
Net income	$ 194.2	$ 20
Net income (loss) per share, basic (in usd per share)	$ 0.63	$ 0.07
Net income (loss) per share, diluted (in usd per share)	$ 0.56	$ 0.06
Weighted-average shares used to compute net income (loss) per share, basic (in shares)	310.1	299.8
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)	349.8	338.4
Product
Revenue:
Revenue:	$ 341.1	$ 330
Cost of revenue:
Cost of revenue:	77.4	120.1
Subscription and support
Revenue:
Revenue:	1,537	1,233.4
Cost of revenue:
Cost of revenue:	$ 395.4	$ 341.8

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 194.2	$ 20
Other comprehensive income (loss), net of tax:
Change in unrealized gains (losses) on investments	(18.2)	(27.8)
Change in unrealized gains (losses)	(40.9)	(42.5)
Net realized (gains) losses reclassified into earnings	9.3	14.8
Net change on cash flow hedges	(31.6)	(27.7)
Other comprehensive loss	(49.8)	(55.5)
Comprehensive income (loss)	$ 144.4	$ (35.5)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common stock	Common stock and additional paid in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Common stock, beginning balance (in shares) at Jul. 31, 2022		298,800,000
Beginning balance at Jul. 31, 2022	$ 210		$ 1,932.7	$ (55.6)	$ (1,667.1)
Increase (decrease) in stockholders' equity
Net income	20				20
Other comprehensive income (loss)	(55.5)			(55.5)
Issuance of common stock in connection with employee equity incentive plans (in shares)		3,500,000
Issuance of common stock in connection with employee equity incentive plans	68.2		68.2
Taxes paid related to net share settlement of equity awards	(13.9)		(13.9)
Share-based compensation for equity-based awards	279.2		279.2
Common stock, ending balance (in shares) at Oct. 31, 2022		302,300,000
Ending balance at Oct. 31, 2022	$ 508		2,266.2	(111.1)	(1,647.1)
Common stock, beginning balance (in shares) at Jul. 31, 2023	308,300,000	308,300,000
Beginning balance at Jul. 31, 2023	$ 1,748.4		3,019	(43.2)	(1,227.4)
Increase (decrease) in stockholders' equity
Net income	194.2				194.2
Other comprehensive income (loss)	(49.8)			(49.8)
Issuance of common stock in connection with employee equity incentive plans (in shares)		2,600,000
Issuance of common stock in connection with employee equity incentive plans	87		87
Taxes paid related to net share settlement of equity awards	(15.5)		(15.5)
Share-based compensation for equity-based awards	273.1		273.1
Repurchase and retirement of common stock (in shares)		(300,000)
Repurchase and retirement of common stock	(66.7)		(66.7)
Settlement of convertible notes (in shares)		300,000
Settlement of convertible notes	$ (0.2)		(0.2)
Settlement of note hedges (in shares)		(300,000)
Settlement of warrants (in shares)		3,100,000
Common stock, ending balance (in shares) at Oct. 31, 2023	313,700,000	313,700,000
Ending balance at Oct. 31, 2023	$ 2,170.5		$ 3,296.7	$ (93)	$ (1,033.2)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities
Net income	$ 194.2	$ 20
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based compensation for equity-based awards	271	266
Depreciation and amortization	64.3	70.7
Amortization of deferred contract costs	105.5	97
Amortization of debt issuance costs	1	1.8
Reduction of operating lease right-of-use assets	12.4	12.1
Amortization of investment premiums, net of accretion of purchase discounts	(14.7)	1.7
Changes in operating assets and liabilities:
Accounts receivable, net	1,050.2	904.4
Financing receivables, net	(43.6)	(12.4)
Deferred contract costs	(63.3)	(60.1)
Prepaid expenses and other assets	54	(28.7)
Accounts payable	(0.4)	(1)
Accrued compensation	(216.9)	(192.3)
Accrued and other liabilities	(34.1)	(28.1)
Deferred revenue	146.4	185.6
Net cash provided by operating activities	1,526	1,236.7
Cash flows from investing activities
Purchases of investments	(854.7)	(2,112.8)
Proceeds from sales of investments	304.6	485
Proceeds from maturities of investments	457.9	347.6
Purchases of property, equipment, and other assets	(36.8)	(39.6)
Net cash used in investing activities	(129)	(1,319.8)
Cash flows from financing activities
Repayments of convertible senior notes	(46)	0
Repurchases of common stock	(66.7)	(22.7)
Proceeds from sales of shares through employee equity incentive plans	86.4	67.7
Payments for taxes related to net share settlement of equity awards	(15.5)	(13.9)
Net cash provided by (used in) financing activities	(41.8)	31.1
Net increase (decrease) in cash, cash equivalents, and restricted cash	1,355.2	(52)
Cash, cash equivalents, and restricted cash - beginning of period	1,142.2	2,124.8
Cash, cash equivalents, and restricted cash - end of period	$ 2,497.4	$ 2,072.8

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	Oct. 31, 2023	Oct. 31, 2022
Statement of Cash Flows [Abstract]
Cash and cash equivalents	$ 2,491.4	$ 2,067.2
Restricted cash	6	5.6
Total cash, cash equivalents, and restricted cash	$ 2,497.4	$ 2,072.8
Restricted Cash, Statement of Financial Position	Prepaid expenses and other current assets	Prepaid expenses and other current assets

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies (Notes)	3 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Summary of Significant Accounting Policies	Description of Business and Summary of Significant Accounting Policies Description of Business Palo Alto Networks, Inc. (the “Company,” “we,” “us,” or “our”), headquartered in Santa Clara, California, was incorporated in March 2005 under the laws of the State of Delaware and commenced operations in April 2005. We empower enterprises, organizations, service providers, and government entities to secure their users, networks, clouds, and endpoints by delivering comprehensive cybersecurity enabled by artificial intelligence and automation. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), consistent in all material respects with those applied in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on September 1, 2023. The condensed consolidated financial statements include our accounts and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. Our condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and the accompanying notes. We base our estimates on assumptions, both historical and forward looking, that we believe are reasonable. Actual results could differ materially from those estimates due to risks and uncertainties, including uncertainty in the current economic environment. Summary of Significant Accounting Policies There have been no material changes to our significant accounting policies as of and for the three months ended October 31, 2023, as compared to the significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023.

Revenue (Notes)

Revenue (Notes)	3 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table presents revenue by geographic theater (in millions): Three Months Ended October 31, 2023 2022 Revenue: Americas United States $ 1,204.3 $ 1,006.3 Other Americas 82.3 64.4 Total Americas 1,286.6 1,070.7 Europe, the Middle East, and Africa (“EMEA”) 364.9 307.9 Asia Pacific and Japan (“APAC”) 226.6 184.8 Total revenue $ 1,878.1 $ 1,563.4 The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 31, 2023 2022 Revenue: Product $ 341.1 $ 330.0 Subscription and support Subscription 988.3 764.0 Support 548.7 469.4 Total subscription and support 1,537.0 1,233.4 Total revenue $ 1,878.1 $ 1,563.4 Deferred Revenue During the three months ended October 31, 2023 and 2022, we recognized approximately $1.4 billion and $1.1 billion of revenue pertaining to amounts that were deferred as of July 31, 2023 and 2022, respectively. Remaining Performance Obligations Remaining performance obligations were $10.4 billion as of October 31, 2023, of which we expect to recognize as revenue approximately $5.0 billion over the next 12 months and the remainder thereafter.

Fair Value Measurements (Notes)

Fair Value Measurements (Notes)	3 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents our financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 July 31, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,595.3 $ — $ — $ 1,595.3 $ 476.1 $ — $ — $ 476.1 Commercial paper — 297.0 — 297.0 — 151.4 — 151.4 Corporate debt securities — 8.6 — 8.6 — — — — U.S. government and agency securities — 24.9 — 24.9 — — — — Total cash equivalents 1,595.3 330.5 — 1,925.8 476.1 151.4 — 627.5 Short-term investments: Certificates of deposit — 34.0 — 34.0 — 48.1 — 48.1 Commercial paper — 136.8 — 136.8 — 213.8 — 213.8 Corporate debt securities — 1,038.2 — 1,038.2 — 798.0 — 798.0 U.S. government and agency securities — 148.0 — 148.0 — 190.6 — 190.6 Non-U.S. government and agency securities — 33.7 — 33.7 — — — — Asset-backed securities — 11.7 — 11.7 — 4.2 — 4.2 Total short-term investments — 1,402.4 — 1,402.4 — 1,254.7 — 1,254.7 October 31, 2023 July 31, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Long-term investments: Corporate debt securities — 2,367.0 — 2,367.0 — 2,484.3 — 2,484.3 U.S. government and agency securities — 71.2 — 71.2 — 22.0 — 22.0 Non-U.S. government and agency securities — 27.9 — 27.9 — 36.6 — 36.6 Asset-backed securities — 522.8 — 522.8 — 505.0 — 505.0 Total long-term investments — 2,988.9 — 2,988.9 — 3,047.9 — 3,047.9 Prepaid expenses and other current assets: Foreign currency forward contracts — 5.6 — 5.6 — 19.1 — 19.1 Total prepaid expenses and other current assets — 5.6 — 5.6 — 19.1 — 19.1 Other assets: Foreign currency forward contracts — — — — — 1.7 — 1.7 Total other assets — — — — — 1.7 — 1.7 Total assets measured at fair value $ 1,595.3 $ 4,727.4 $ — $ 6,322.7 $ 476.1 $ 4,474.8 $ — $ 4,950.9 Accrued and other liabilities: Foreign currency forward contracts $ — $ 44.6 $ — $ 44.6 $ — $ 18.7 $ — $ 18.7 Total accrued and other liabilities — 44.6 — 44.6 — 18.7 — 18.7 Other long-term liabilities: Foreign currency forward contracts — — — — — 1.6 — 1.6 Total other long-term liabilities — — — — — 1.6 — 1.6 Total liabilities measured at fair value $ — $ 44.6 $ — $ 44.6 $ — $ 20.3 $ — $ 20.3 Refer to Note 8. Debt for the carrying amount and estimated fair value of our convertible senior notes as of October 31, 2023 and July 31, 2023.

Cash Equivalents and Investment

Cash Equivalents and Investments (Notes)	3 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Investments	Cash Equivalents and Investments Available-for-sale Debt Securities The following tables summarize the amortized cost, unrealized gains and losses, and fair value of our available-for-sale debt securities as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Commercial paper $ 297.0 $ — $ — $ 297.0 Corporate debt securities 8.6 — — 8.6 U.S. government and agency securities 24.9 — — 24.9 Total available-for-sale cash equivalents $ 330.5 $ — $ — $ 330.5 Investments: Certificates of deposit $ 34.0 $ — $ — $ 34.0 Commercial paper 136.9 — (0.1) 136.8 Corporate debt securities 3,453.7 0.1 (48.6) 3,405.2 U.S. government and agency securities 219.9 0.1 (0.8) 219.2 Non-U.S. government and agency securities 62.4 — (0.8) 61.6 Asset-backed securities 539.1 0.1 (4.7) 534.5 Total available-for-sale investments $ 4,446.0 $ 0.3 $ (55.0) $ 4,391.3 July 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Commercial paper $ 151.4 $ — $ — $ 151.4 Total available-for-sale cash equivalents $ 151.4 $ — $ — $ 151.4 Investments: Certificates of deposit $ 48.1 $ — $ — $ 48.1 Commercial paper 214.1 — (0.3) 213.8 Corporate debt securities 3,313.5 1.3 (32.5) 3,282.3 U.S. government and agency securities 214.2 — (1.6) 212.6 Non-U.S. government and agency securities 37.2 — (0.6) 36.6 Asset-backed securities 512.0 0.2 (3.0) 509.2 Total available-for-sale investments $ 4,339.1 $ 1.5 $ (38.0) $ 4,302.6 As of October 31, 2023, the gross unrealized losses that have been in a continuous unrealized loss position for less than 12 months were $40.4 million, which were related to $3.3 billion of available-for-sale debt securities, and the gross unrealized losses that have been in a continuous unrealized loss position for more than 12 months were $14.6 million, which were related to $922.5 million of available-for-sale debt securities. As of July 31, 2023 the gross unrealized losses that have been in a continuous unrealized loss position for less than 12 months were $30.7 million, which were related to $3.4 billion of available-for-sale debt securities, and the gross unrealized losses that have been in a continuous unrealized loss position for more than 12 months were $7.3 million, which were related to $481.8 million of available-for-sale debt securities. Unrealized losses related to our available-for-sale debt securities are primarily due to interest rate fluctuations as opposed to credit quality. We do not intend to sell any of the securities in an unrealized loss position and it is not likely that we would be required to sell these securities before recovery of their amortized cost basis, which may be at maturity. We did not recognize any credit losses related to our available-for-sale debt securities during the three months ended October 31, 2023 and 2022. The following table summarizes the amortized cost and fair value of our available-for-sale debt securities as of October 31, 2023, by contractual years-to-maturity (in millions): Amortized Cost Fair Value Due within one year $ 1,742.4 $ 1,732.9 Due between one and three years 2,173.8 2,145.2 Due between three and five years 743.4 728.1 Due between five and ten years 61.3 60.8 Due after ten years 55.6 54.8 Total $ 4,776.5 $ 4,721.8 Marketable Equity Securities Marketable equity securities consist of money market funds and are included in cash and cash equivalents on our condensed consolidated balance sheets. As of October 31, 2023 and July 31, 2023, the carrying values of our marketable equity securities were $1.6 billion and $476.1 million, respectively. There were no unrealized gains or losses recognized for these securities during the three months ended October 31, 2023 and 2022.

Financing Receivables (Notes)

Financing Receivables (Notes)	3 Months Ended
	Oct. 31, 2023
Receivables [Abstract]
Financing Receivables	Financing Receivables The following table summarizes our short-term and long-term financing receivables as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 July 31, 2023 Short-term financing receivables, gross $ 499.8 $ 435.1 Unearned income (49.3) (42.9) Allowance for credit losses (4.6) (3.4) Short-term financing receivables, net $ 445.9 $ 388.8 Long-term financing receivables, gross $ 689.8 $ 698.6 Unearned income (42.0) (39.2) Allowance for credit losses (8.0) (6.1) Long-term financing receivables, net $ 639.8 $ 653.3 Our financing receivables portfolio primarily consisted of high-quality investment-grade receivables as of October 31, 2023 and July 31, 2023. There was no significant activity in allowance for credit losses during the three months ended October 31, 2023 and 2022. Past due amounts on financing receivables were not material as of October 31, 2023 and July 31, 2023.

Derivative Instruments (Notes)

Derivative Instruments (Notes)	3 Months Ended
	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments We are exposed to foreign currency exchange risk. Our revenue is transacted in U.S. dollars, however, a portion of our operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. We enter into foreign currency derivative contracts with maturities of 24 months or less, which we designate as cash flow hedges, to manage the foreign currency exchange risk associated with our operating expenditures. As of October 31, 2023 and July 31, 2023, the total notional amount of our outstanding foreign currency forward contracts was $777.9 million and $957.5 million, respectively. Refer to Note 3. Fair Value Measurements for the fair value of our derivative instruments as reported on our condensed consolidated balance sheets as of October 31, 2023 and July 31, 2023. As of October 31, 2023, unrealized gains and losses in accumulated other comprehensive income (“AOCI”) related to our cash flow hedges were a $31.0 million net loss, of which $29.0 million in losses are expected to be recognized into earnings within the next 12 months. As of July 31, 2023, unrealized gains and losses in AOCI related to our cash flow hedges were a $0.7 million net gain.

Intangible Assets (Notes)

Intangible Assets (Notes)	3 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Purchased Intangible Assets The following table presents details of our purchased intangible assets as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 July 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Intangible assets subject to amortization: Developed technology $ 633.2 $ (448.5) $ 184.7 $ 633.2 $ (429.4) $ 203.8 Customer relationships 172.7 (79.3) 93.4 172.7 (73.9) 98.8 Acquired intellectual property 14.6 (6.5) 8.1 14.6 (6.2) 8.4 Trade name and trademarks 9.4 (9.4) — 9.4 (9.4) — Other 0.9 (0.5) 0.4 0.9 (0.4) 0.5 Total intangible assets subject to amortization 830.8 (544.2) 286.6 830.8 (519.3) 311.5 Intangible assets not subject to amortization: In-process research and development 3.9 — 3.9 3.9 — 3.9 Total purchased intangible assets $ 834.7 $ (544.2) $ 290.5 $ 834.7 $ (519.3) $ 315.4 We recognized amortization expense of $24.9 million and $29.1 million for the three months ended October 31, 2023 and 2022, respectively. The following table summarizes estimated future amortization expense of our intangible assets subject to amortization as of October 31, 2023 (in millions): Fiscal years ending July 31, Total Remaining 2024 2025 2026 2027 2028 2029 and Thereafter Future amortization expense $ 286.6 $ 73.0 $ 84.2 $ 62.4 $ 35.3 $ 13.7 $ 18.0

Debt (Notes)

Debt (Notes)	3 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt Convertible Senior Notes In July 2018, we issued $1.7 billion aggregate principal amount of 0.75% Convertible Senior Notes due 2023 (the “2023 Notes”) and in June 2020, we issued $2.0 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2025 (the “2025 Notes,” and together with the 2023 Notes, the “Notes”). The 2023 Notes were converted prior to or settled on the maturity date of July 1, 2023 in accordance with their terms. The 2025 Notes bear interest at a fixed rate of 0.375% per year, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The 2025 Notes are governed by an indenture between us, as the issuer, and U.S. Bank National Association, as Trustee (the “Indenture”). The 2025 Notes are unsecured, unsubordinated obligations and the Indenture governing the 2025 Notes does not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness, or the issuance or repurchase of securities by us or any of our subsidiaries. The 2025 Notes mature on June 1, 2025. We may redeem for cash all or any portion of the 2025 Notes, at our option, on or after June 5, 2023 and prior to the 31st scheduled trading day immediately preceding the maturity date if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on and including the trading day preceding the date on which we provide notice of redemption. The redemption will be at a price equal to 100% of the principal amount of the 2025 Notes and adjusted for interest. If we call any or all of the 2025 Notes for redemption, holders may convert such 2025 Notes called for redemption at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date. The 2025 Notes are convertible for an initial 20.1 million shares of our common stock at a conversion rate of approximately 10.0806 shares of common stock per $1,000 principal amount, which is equal to an initial conversion price of approximately $99.20 per share of common stock, subject to adjustments. Holders of the 2025 Notes may surrender their 2025 Notes for conversion at their option at any time prior to the close of business on the business day immediately preceding March 1, 2025 only under the following circumstances: • during any fiscal quarter commencing after the fiscal quarters ending on October 31, 2020 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the 2025 Notes on each applicable trading day (the “sale price condition”); • during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the 2025 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the 2025 Notes on each such trading day; or • upon the occurrence of specified corporate events. On or after March 1, 2025, holders may surrender all or any portion of their 2025 Notes for conversion at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date regardless of the foregoing conditions, and such conversions will be settled upon the maturity date. Upon conversion, holders of the 2025 Notes will receive cash equal to the aggregate principal amount of the 2025 Notes to be converted, and, at our election, cash and/or shares of our common stock for any amounts in excess of the aggregate principal amount of the 2025 Notes being converted. The conversion price will be subject to adjustment in some events. Holders of the 2025 Notes who convert their 2025 Notes in connection with certain corporate events that constitute a “make-whole fundamental change” under the Indenture are, under certain circumstances, entitled to an increase in the conversion rate. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” under the Indenture, holders of the 2025 Notes may require us to repurchase for cash all or a portion of the 2025 Notes at a repurchase price equal to 100% of the principal amount of the 2025 Notes plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. Holders of the 2025 Notes were able to early convert their 2025 Notes during the fiscal quarter ended October 31, 2023 as the sales price condition had been met during the fiscal quarter ended July 31, 2023. During the three months ended October 31, 2023, holders of the 2025 Notes converted $46.0 million in aggregate principal amount of the 2025 Notes, which we repaid in cash. We also issued 0.3 million shares of our common stock to the holders of the 2025 Notes for the conversion value in excess of the principal amount. These shares were fully offset by shares we received from the corresponding exercise of the associated note hedges. The sale price condition for the 2025 Notes was met during the fiscal quarter ended October 31, 2023 and as a result, holders may convert their 2025 Notes during the fiscal quarter ending January 31, 2024. The net carrying amount of the 2025 Notes was classified as a current liability on our condensed consolidated balance sheet as of October 31, 2023. The following table sets forth the net carrying amount of our 2025 Notes (in millions): October 31, 2023 July 31, 2023 Principal $ 1,953.3 $ 1,999.3 Less: debt issuance costs, net of amortization (6.6) (7.8) Net carrying amount $ 1,946.7 $ 1,991.5 The total estimated fair value of the 2025 Notes was $4.8 billion as of October 31, 2023 and $5.0 billion as of July 31, 2023, respectively. The fair value was determined based on the closing trading price per $100 of the 2025 Notes as of the last day of trading for the period. We consider the fair value of the 2025 Notes as of October 31, 2023 and July 31, 2023 to be a Level 2 measurement. The fair value of the 2025 Notes is primarily affected by the trading price of our common stock and market interest rates. The following table sets forth interest expense recognized related to the Notes (dollars in millions): Three Months Ended October 31, 2023 2022 2023 Notes 2025 Notes Total 2023 Notes 2025 Notes Total Contractual interest expense $ — $ 1.9 $ 1.9 $ 3.2 $ 1.8 $ 5.0 Amortization of debt issuance costs — 1.0 1.0 0.7 1.1 1.8 Total interest expense $ — $ 2.9 $ 2.9 $ 3.9 $ 2.9 $ 6.8 Effective interest rate — % 0.6 % 0.9 % 0.6 % Note Hedges To minimize the impact of potential economic dilution upon conversion of our convertible senior notes, we entered into separate convertible note hedge transactions (the “2023 Note Hedges,” with respect to the 2023 Notes, the “2025 Note Hedges,” with respect to the 2025 Notes, and the 2023 Note Hedges together with 2025 Note Hedges, the “Note Hedges”) with respect to our common stock concurrent with the issuance of each series of the Notes. Upon the settlement of the 2023 Notes, we exercised the corresponding portion of our 2023 Note Hedges during the year ended July 31, 2023 and received shares of our common stock that fully offset the shares issued in excess of the principal amount of the converted 2023 Notes. The 2023 Note Hedges expired upon maturity of the 2023 Notes. The 2025 Note Hedges cover up to 20.1 million shares of our common stock at a strike price per share that corresponds to the initial conversion price of the 2025 Notes, which are also subject to adjustment, and are exercisable upon conversion of the 2025 Notes. The 2025 Note Hedges will expire upon maturity of the 2025 Notes. The 2025 Note Hedges are separate transactions and are not part of the terms of the 2025 Notes. Holders of the 2025 Notes will not have any rights with respect to the 2025 Note Hedges. Any shares of our common stock receivable by us under the 2025 Note Hedges are excluded from the calculation of diluted earnings per share as they are antidilutive. We paid an aggregate amount of $370.8 million for the 2025 Note Hedges, which is included in additional paid-in capital on our condensed consolidated balance sheets. As a result of the conversions of the 2025 Notes settled during the three months ended October 31, 2023, we exercised the corresponding portion of our 2025 Note Hedges and received 0.3 million shares of our common stock during the period. Warrants Separately, but concurrently with the issuance of each series of our convertible senior notes, we entered into transactions whereby we sold warrants (the “2023 Warrants,” with respect to the 2023 Notes, the “2025 Warrants,” with respect to the 2025 Notes, and the 2023 Warrants together with the 2025 Warrants, the “Warrants”) to acquire shares of our common stock, subject to anti-dilution adjustments. The 2023 Warrants and 2025 Warrants are exercisable over 60 scheduled trading days beginning October 2023 and September 2025, respectively. The following table presents details of our Warrants (in millions, except per share data): Initial Number of Shares Strike Price per Share Aggregate Proceeds 2023 Warrants 19.1 $ 139.27 $ 145.4 2025 Warrants 20.1 $ 136.16 $ 202.8 The shares issuable under the Warrants are included in the calculation of diluted earnings per share when the average market value per share of our common stock for the reporting period exceeds the applicable strike price for such series of Warrants. The Warrants are separate transactions and are not part of either series of Notes or Note Hedges and are not remeasured through earnings each reporting period. Holders of the Notes of either series will not have any rights with respect to the Warrants. The aggregate proceeds received from the sale of the Warrants are included in additional paid-in capital on our condensed consolidated balance sheets. During the three months ended October 31, 2023, we net settled a portion of the 2023 Warrants with 3.1 million shares of our common stock with a fair value of $763.5 million. The number of net shares issued was determined based on the number of 2023 Warrants exercised multiplied by the difference between the strike price of the 2023 Warrants and their daily volume-weighted-average stock price. As of October 31, 2023, up to 12.1 million shares of our common stock were issuable for gross settlement under the remaining outstanding 2023 Warrants, which will be net settled when exercised through the end of December 2023. Revolving Credit Facility On April 13, 2023, we entered into a credit agreement (the “Credit Agreement”) with certain institutional lenders that provides for a $400.0 million unsecured revolving credit facility (the “Credit Facility”), with an option to increase the amount of the Credit Facility by up to an additional $350.0 million, subject to certain conditions. The Credit Facility matures on April 13, 2028. The borrowings under the Credit Facility bear interest, at our option, at a base rate plus a spread of 0.000% to 0.375%, or an adjusted term Secured Overnight Financing Rate (“SOFR”) plus a spread of 1.000% to 1.375%, in each case with such spread being determined based on our leverage ratio. We are obligated to pay an ongoing commitment fee on undrawn amounts at a rate of 0.090% to 0.150%, depending on our leverage ratio. The interest rates and commitment fees are also subject to upward and downward adjustments based on our progress towards the achievement of certain sustainability goals related to greenhouse gas emissions. As of October 31, 2023, there were no amounts outstanding and we were in compliance with all covenants under the Credit Agreement.

Commitments and Contingencies (

Commitments and Contingencies (Notes)	3 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments Manufacturing Purchase Commitments In order to reduce manufacturing lead times and plan for adequate supply, we enter into agreements with manufacturing partners and component suppliers to procure inventory based on our demand forecasts. The following table presents details of the aggregate future minimum or fixed purchase commitments under these arrangements, excluding obligations under contracts that we can cancel as of October 31, 2023 (in millions): Fiscal years ending July 31, Total Remaining 2024 2025 2026 2027 2028 2029 and Thereafter Manufacturing purchase commitments $ 188.2 $ 113.2 $ 35.0 $ 40.0 $ — $ — $ — Other Purchase Commitments We have entered into various non-cancelable agreements with certain service providers, under which we are committed to minimum or fixed purchases. The following table presents details of the aggregate future non-cancelable purchase commitments under these agreements as of October 31, 2023 (in millions): Fiscal years ending July 31, Total Remaining 2024 2025 2026 2027 2028 2029 and Thereafter Other purchase commitments $ 1,383.3 $ 11.3 $ 387.4 $ 499.4 $ 483.8 $ 0.6 $ 0.8 Additionally, we have a $153.3 million minimum purchase commitment with a service provider through September 2027 with no specified annual commitments. Guarantee In October 2023, we established a multi-currency notional cash pool for a certain number of our entities with a third-party bank. As part of the notional cash pool agreement, the bank extends overdraft credit to our participating entities as needed, provided that the overall notionally pooled balance of all accounts in the pool at the end of each day is positive. In the unlikely event of a default, any overdraft balances incurred would be guaranteed by our collective entities participating in the pool. Litigation We are subject to legal proceedings, claims, tax matters, and litigation arising in the ordinary course of business, including, for instance, intellectual property and patent litigation. We accrue for contingencies when we believe that a loss is probable and that we can reasonably estimate the amount of any such loss. As of October 31, 2023, we have not recorded any significant accruals for loss contingencies associated with such matters. Legal matters could include speculative, substantial or indeterminate monetary amounts. Significant judgment is required to determine both the likelihood of there being a loss and the estimated amount of a loss related to such matters, and we may be unable to estimate the reasonably possible loss or range of loss. The outcomes of outstanding legal matters are inherently unpredictable, and could, either individually or in aggregate, have a material adverse effect on us and our results of operations. To the extent there is a reasonable possibility that a loss exceeding any amounts already recognized may be incurred, we will either disclose the estimated additional loss or state that such an estimate cannot be made. The following matters arose in the ordinary course of business. Centripetal Networks, Inc. v. Palo Alto Networks On March 12, 2021, Centripetal Networks, Inc., filed a lawsuit against us in the United States District Court for the Eastern District of Virginia (“E.D.VA”). The lawsuit alleges that our products infringe multiple Centripetal patents. We successfully challenged certain of these patents, which were found unpatentable by the U.S. Patent and Trademark Office. The complaint requests injunctive relief, monetary damages, and attorneys fees. The US District Court E.D.VA has set a trial date of January 22, 2024 on the remaining patents. In addition, Centripetal filed infringement contentions on certain of their patents in the European Patent Office in Germany, to which we filed invalidity challenges. Those matters are still pending. We are unable, at this time, to reasonably estimate a possible loss or potential range of loss, if any. Finjan, Inc. v. Palo Alto Networks On November 4, 2014, Finjan, Inc., filed a lawsuit against us in the United States District Court for the Northern District of California. The lawsuit alleges that our products infringe multiple Finjan patents. The complaint requests injunctive relief, monetary damages, and attorneys fees. The court has moved the trial date from April 8, 2024 to October 21, 2024. We are unable, at this time, to reasonably estimate a possible loss or potential range of loss, if any. Taasera v. Palo Alto Networks On March 22, 2022, we filed a declaratory judgment action in the United States District Court for the Southern District of New York (“S.D.N.Y”) seeking a ruling that we are not infringing various Taasera patents. Taasera challenged jurisdiction in S.D.N.Y, which issue is currently on appeal with the Federal Circuit. Pursuant to an order of the Judicial Panel on Multidistrict Litigation, this matter has been consolidated in the United States District Court for the Eastern District of Texas with several other patent infringement matters brought by Taasera. The court moved the start date to April 15, 2024, as the start of consecutive trials of these consolidated matters. The complaint requests injunctive relief, monetary damages, and attorneys fees. We are unable, at this time, to reasonably estimate a possible loss or potential range of loss, if any.

Stockholders' Equity (Notes)

Stockholders' Equity (Notes)	3 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Stockholders’ Equity	Stockholders’ Equity Share Repurchase Program In February 2019, our board of directors authorized a $1.0 billion share repurchase program, which is funded from available working capital. In December 2020, August 2021, and August 2022, our board of directors authorized additional $700.0 million, $676.1 million, and $915.0 million increases to this share repurchase program, respectively, bringing the total authorization under this share repurchase program to $3.3 billion (our “current authorization”). The expiration date of our current authorization was extended to December 31, 2023, and our repurchase program may be suspended or discontinued at any time. Repurchases may be made at management’s discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchase techniques, 10b5-1 trading plans, or a combination of the foregoing. During the three months ended October 31, 2023, we repurchased and retired 0.3 million shares of our common stock under our current repurchase authorization for an aggregate purchase price of $66.7 million, including transaction costs, at an average price of $226.67. During the three months ended October 31, 2022, we did not repurchase shares of our common stock, and paid $22.7 million related to share repurchases of our common stock that were not settled as of July 31, 2022. As of October 31, 2023, $683.3 million remained available for future share repurchases under our current repurchase authorization. The total price of the shares repurchased and related transaction costs are reflected as a reduction to common stock and additional paid-in capital on our condensed consolidated balance sheets.

Equity Award Plans (Notes)

Equity Award Plans (Notes)	3 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity Award Plans	Equity Award Plans Restricted Stock Unit (“RSU”) and Performance-Based Stock Unit (“PSU”) Activities The following table summarizes the RSU and PSU activity under our stock plans during the three months ended October 31, 2023 (in millions, except per share amounts): RSUs Outstanding PSUs Outstanding Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Balance—July 31, 2023 12.1 $ 142.61 $ 3,013.0 5.0 $ 128.64 $ 1,242.3 Granted (1) 0.5 $ 245.46 2.1 $ 183.03 Vested (1.6) $ 123.43 (0.5) $ 145.93 Forfeited (0.4) $ 143.47 (0.4) $ 133.97 Balance—October 31, 2023 10.6 $ 150.58 $ 2,574.9 6.2 $ 145.51 $ 1,516.4 (1) For PSUs, shares granted represent the aggregate maximum number of shares that may be earned and issued with respect to these awards over their full terms. Our RSUs generally vest over a period of three Our PSUs generally vest over a period of one During the three months ended October 31, 2023 and 2022, we granted 2.0 million and 1.6 million shares of PSUs, respectively, which contain service, performance and market conditions. The service conditions are satisfied after a period of one The fair value of the PSUs subject to market conditions is estimated on the grant date using a Monte Carlo simulation model. The following table summarizes the assumptions used and the resulting grant-date fair value of our PSUs subject to market conditions granted during the three months ended October 31, 2023 and 2022: Three Months Ended October 31, 2023 2022 Volatility 40.8% - 43.4% 39.6% - 44.8% Expected term (in years) 0.9 - 2.9 1.0 - 4.0 Dividend yield 0.0 % 0.0 % Risk-free interest rate 4.9% - 5.3% 3.2% - 3.6% Grant-date fair value per share $346.92 - $394.63 $105.60 - $280.41 Performance Stock Option (“PSO”) Activities We have granted PSOs with both service and market conditions. The market conditions were achieved when certain stock price targets were met. As of October 31, 2023, all of our outstanding PSOs have been fully vested. The maximum contractual term of our outstanding PSOs is seven and a half years from the date of grant in fiscal year 2018 and 2019. The following table summarizes the PSO activity under our stock plans during the three months ended October 31, 2023 (in millions, except per share amounts): Number of Shares Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Balance—July 31, 2023 6.4 $ 65.20 2.2 $ 1,184.6 Exercised (0.1) $ 64.50 Balance—October 31, 2023 6.3 $ 65.22 1.9 $ 1,116.0 Exercisable—October 31, 2023 6.3 $ 65.22 1.9 $ 1,116.0 Share-Based Compensation The following table summarizes share-based compensation included in costs and expenses (in millions): Three Months Ended October 31, 2023 2022 Cost of product revenue $ 2.4 $ 2.4 Cost of subscription and support revenue 30.6 28.8 Research and development 120.1 118.0 Sales and marketing 79.2 87.4 General and administrative 38.7 29.4 Total share-based compensation $ 271.0 $ 266.0 As of October 31, 2023, total compensation cost related to unvested share-based awards not yet recognized was $1.9 billion. This cost is expected to be amortized over a weighted-average period of approximately 2.7 years.

Income Taxes (Notes)

Income Taxes (Notes)	3 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended October 31, 2023 and 2022, our provision for income taxes reflected effective tax rates of 31.3% and 41.9%, respectively. Our income taxes for the three months ended October 31, 2023 and 2022 were primarily due to U.S. federal and state income taxes, withholding taxes, and foreign income taxes. Our effective tax rate decreased for the three months ended October 31, 2023 compared to the same period in 2022 primarily due to higher tax benefits from our share-based compensation. Our effective tax rates differed from the U.S. statutory tax rate primarily due to changes in our valuation allowance. We maintain a full valuation allowance for domestic and certain foreign deferred tax assets, including net operating loss carryforwards and certain domestic tax credits. We regularly evaluate the need for a valuation allowance. Due to recent profitability, a reversal of our valuation allowance in certain jurisdictions in the near future is reasonably possible.

Net Income (Loss) Per Share (No

Net Income (Loss) Per Share (Notes)	3 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income Per ShareBasic net income per share is computed by dividing net income by basic weighted-average shares outstanding during the period. Diluted net income per share is computed by dividing net income by diluted weighted-average shares outstanding during the period giving effect to all potentially dilutive securities to the extent they are dilutive. Potentially dilutive securities include shares issuable upon conversion of our convertible senior notes using the if-converted method, warrants related to the issuance of convertible senior notes, and equity awards under our employee equity incentive plans using the treasury stock method. The following table presents the computation of basic and diluted net income per share of common stock (in millions, except per share data): Three Months Ended October 31, 2023 2022 Net income $ 194.2 $ 20.0 Weighted-average shares used to compute net income per share, basic 310.1 299.8 Weighted-average effect of potentially dilutive securities: Convertible senior notes 11.6 17.8 Warrants related to the issuance of convertible senior notes 16.0 7.8 Employee equity incentive plans 12.1 13.0 Weighted-average shares used to compute net income per share, diluted 349.8 338.4 Net income per share, basic $ 0.63 $ 0.07 Net income per share, diluted $ 0.56 $ 0.06 The following securities were excluded from the computation of diluted net income per share of common stock as their effect would have been antidilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the applicable period (in millions): Three Months Ended October 31, 2023 2022 Employee equity incentive plans 2.6 2.7

Other Income (Expense), Net (No

Other Income (Expense), Net (Notes)	3 Months Ended
	Oct. 31, 2023
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other Income, Net The following table sets forth the components of other income, net (in millions): Three Months Ended October 31, 2023 2022 Interest income $ 71.2 $ 29.4 Foreign currency exchange gains (losses), net 5.1 4.4 Other, net (6.0) (7.8) Total other income, net $ 70.3 $ 26.0

Subsequent Events (Notes)

Subsequent Events (Notes)	3 Months Ended
	Oct. 31, 2023
Subsequent Events [Abstract]
Subsequent Event	Subsequent Events Acquisitions On October 29, 2023, we entered into a definitive agreement to acquire Dig Security Solutions Ltd., a privately-held cyber security company (“Dig”), for total consideration of approximately $295.0 million, including approximately $232.0 million in cash and approximately $63.0 million in replacement awards, subject to adjustment. We expect the acquisition will enhance our Prisma Cloud capabilities with a data security posture management solution that is intended to provide customers with visibility into, and secure data stored across, their multi-cloud environments. On November 6, 2023, we entered into a definitive agreement to acquire Talon Cyber Security Ltd., a privately-held cyber security company (“Talon”), for total consideration of approximately $550.0 million, including approximately $434.9 million in cash and approximately $115.1 million in replacement awards, subject to adjustment. We expect the acquisition will support Prisma SASE’s approach to provide secure access to business applications for unmanaged and personal devices with an enterprise browser. The proposed acquisitions of Dig and Talon are expected to close during our second quarter of fiscal 2024, subject to the satisfaction of customary closing conditions. Share Repurchase On November 16, 2023, our board of directors authorized a $316.7 million increase to our share repurchase program, bringing the total remaining authorization for future share repurchases to $1.0 billion. The expiration date of the repurchase authorization was extended to December 31, 2024, and our repurchase program may be suspended or discontinued at any time without prior notice. Repurchases may be made at management’s discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchase techniques, 10b5-1 trading plans, or a combination of the foregoing.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net income	$ 194.2	$ 20

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Set forth below is certain information regarding Rule 10b5-1 trading plans adopted by our directors and officers (as defined in Rule 16a-1(f)) during the first quarter of fiscal 2024. The Rule 10b5-1 trading plans listed below are each intended to satisfy the affirmative defense of Rule 10b5-1(c). Name Title Date Plan Was Adopted Expiration Date Total Amount of Common Stock to be Sold Under the Plan Dipak Golechha Executive Vice President, Chief Financial Officer September 13, 2023 December 31, 2024 or when all shares have been sold 12,500 Mary Pat McCarthy Director August 22, 2023 August 23, 2024 or when all shares have been sold 4,000
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Dipak Golechha [Member]
Trading Arrangements, by Individual
Name	Dipak Golechha
Title	Executive Vice President, Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 13, 2023
Arrangement Duration	475 days
Aggregate Available	12,500
Mary Pat McCarthy [Member]
Trading Arrangements, by Individual
Name	Mary Pat McCarthy
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 22, 2023
Arrangement Duration	347 days
Aggregate Available	4,000

Description of Business and S_2

Description of Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), consistent in all material respects with those applied in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on September 1, 2023. The condensed consolidated financial statements include our accounts and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. Our condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and the accompanying notes. We base our estimates on assumptions, both historical and forward looking, that we believe are reasonable. Actual results could differ materially from those estimates due to risks and uncertainties, including uncertainty in the current economic environment.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue from external customers by geographic areas	The following table presents revenue by geographic theater (in millions): Three Months Ended October 31, 2023 2022 Revenue: Americas United States $ 1,204.3 $ 1,006.3 Other Americas 82.3 64.4 Total Americas 1,286.6 1,070.7 Europe, the Middle East, and Africa (“EMEA”) 364.9 307.9 Asia Pacific and Japan (“APAC”) 226.6 184.8 Total revenue $ 1,878.1 $ 1,563.4
Revenue from external customers by products and services	The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 31, 2023 2022 Revenue: Product $ 341.1 $ 330.0 Subscription and support Subscription 988.3 764.0 Support 548.7 469.4 Total subscription and support 1,537.0 1,233.4 Total revenue $ 1,878.1 $ 1,563.4

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of fair value of financial assets and liabilities	The following table presents our financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 July 31, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,595.3 $ — $ — $ 1,595.3 $ 476.1 $ — $ — $ 476.1 Commercial paper — 297.0 — 297.0 — 151.4 — 151.4 Corporate debt securities — 8.6 — 8.6 — — — — U.S. government and agency securities — 24.9 — 24.9 — — — — Total cash equivalents 1,595.3 330.5 — 1,925.8 476.1 151.4 — 627.5 Short-term investments: Certificates of deposit — 34.0 — 34.0 — 48.1 — 48.1 Commercial paper — 136.8 — 136.8 — 213.8 — 213.8 Corporate debt securities — 1,038.2 — 1,038.2 — 798.0 — 798.0 U.S. government and agency securities — 148.0 — 148.0 — 190.6 — 190.6 Non-U.S. government and agency securities — 33.7 — 33.7 — — — — Asset-backed securities — 11.7 — 11.7 — 4.2 — 4.2 Total short-term investments — 1,402.4 — 1,402.4 — 1,254.7 — 1,254.7 October 31, 2023 July 31, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Long-term investments: Corporate debt securities — 2,367.0 — 2,367.0 — 2,484.3 — 2,484.3 U.S. government and agency securities — 71.2 — 71.2 — 22.0 — 22.0 Non-U.S. government and agency securities — 27.9 — 27.9 — 36.6 — 36.6 Asset-backed securities — 522.8 — 522.8 — 505.0 — 505.0 Total long-term investments — 2,988.9 — 2,988.9 — 3,047.9 — 3,047.9 Prepaid expenses and other current assets: Foreign currency forward contracts — 5.6 — 5.6 — 19.1 — 19.1 Total prepaid expenses and other current assets — 5.6 — 5.6 — 19.1 — 19.1 Other assets: Foreign currency forward contracts — — — — — 1.7 — 1.7 Total other assets — — — — — 1.7 — 1.7 Total assets measured at fair value $ 1,595.3 $ 4,727.4 $ — $ 6,322.7 $ 476.1 $ 4,474.8 $ — $ 4,950.9 Accrued and other liabilities: Foreign currency forward contracts $ — $ 44.6 $ — $ 44.6 $ — $ 18.7 $ — $ 18.7 Total accrued and other liabilities — 44.6 — 44.6 — 18.7 — 18.7 Other long-term liabilities: Foreign currency forward contracts — — — — — 1.6 — 1.6 Total other long-term liabilities — — — — — 1.6 — 1.6 Total liabilities measured at fair value $ — $ 44.6 $ — $ 44.6 $ — $ 20.3 $ — $ 20.3

Cash Equivalents and Investme_2

Cash Equivalents and Investments (Tables)	3 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of available-for-sale debt securities	The following tables summarize the amortized cost, unrealized gains and losses, and fair value of our available-for-sale debt securities as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Commercial paper $ 297.0 $ — $ — $ 297.0 Corporate debt securities 8.6 — — 8.6 U.S. government and agency securities 24.9 — — 24.9 Total available-for-sale cash equivalents $ 330.5 $ — $ — $ 330.5 Investments: Certificates of deposit $ 34.0 $ — $ — $ 34.0 Commercial paper 136.9 — (0.1) 136.8 Corporate debt securities 3,453.7 0.1 (48.6) 3,405.2 U.S. government and agency securities 219.9 0.1 (0.8) 219.2 Non-U.S. government and agency securities 62.4 — (0.8) 61.6 Asset-backed securities 539.1 0.1 (4.7) 534.5 Total available-for-sale investments $ 4,446.0 $ 0.3 $ (55.0) $ 4,391.3 July 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Commercial paper $ 151.4 $ — $ — $ 151.4 Total available-for-sale cash equivalents $ 151.4 $ — $ — $ 151.4 Investments: Certificates of deposit $ 48.1 $ — $ — $ 48.1 Commercial paper 214.1 — (0.3) 213.8 Corporate debt securities 3,313.5 1.3 (32.5) 3,282.3 U.S. government and agency securities 214.2 — (1.6) 212.6 Non-U.S. government and agency securities 37.2 — (0.6) 36.6 Asset-backed securities 512.0 0.2 (3.0) 509.2 Total available-for-sale investments $ 4,339.1 $ 1.5 $ (38.0) $ 4,302.6
Schedule of contractual maturities of available-for-sale debt securities	The following table summarizes the amortized cost and fair value of our available-for-sale debt securities as of October 31, 2023, by contractual years-to-maturity (in millions): Amortized Cost Fair Value Due within one year $ 1,742.4 $ 1,732.9 Due between one and three years 2,173.8 2,145.2 Due between three and five years 743.4 728.1 Due between five and ten years 61.3 60.8 Due after ten years 55.6 54.8 Total $ 4,776.5 $ 4,721.8

Financing Receivables (Tables)

Financing Receivables (Tables)	3 Months Ended
	Oct. 31, 2023
Receivables [Abstract]
Short- and long-term financing receivables	The following table summarizes our short-term and long-term financing receivables as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 July 31, 2023 Short-term financing receivables, gross $ 499.8 $ 435.1 Unearned income (49.3) (42.9) Allowance for credit losses (4.6) (3.4) Short-term financing receivables, net $ 445.9 $ 388.8 Long-term financing receivables, gross $ 689.8 $ 698.6 Unearned income (42.0) (39.2) Allowance for credit losses (8.0) (6.1) Long-term financing receivables, net $ 639.8 $ 653.3

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of purchased finite-lived intangible assets by major class	The following table presents details of our purchased intangible assets as of October 31, 2023 and July 31, 2023 (in millions): October 31, 2023 July 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Intangible assets subject to amortization: Developed technology $ 633.2 $ (448.5) $ 184.7 $ 633.2 $ (429.4) $ 203.8 Customer relationships 172.7 (79.3) 93.4 172.7 (73.9) 98.8 Acquired intellectual property 14.6 (6.5) 8.1 14.6 (6.2) 8.4 Trade name and trademarks 9.4 (9.4) — 9.4 (9.4) — Other 0.9 (0.5) 0.4 0.9 (0.4) 0.5 Total intangible assets subject to amortization 830.8 (544.2) 286.6 830.8 (519.3) 311.5 Intangible assets not subject to amortization: In-process research and development 3.9 — 3.9 3.9 — 3.9 Total purchased intangible assets $ 834.7 $ (544.2) $ 290.5 $ 834.7 $ (519.3) $ 315.4
Future amortization expense of intangible assets	The following table summarizes estimated future amortization expense of our intangible assets subject to amortization as of October 31, 2023 (in millions): Fiscal years ending July 31, Total Remaining 2024 2025 2026 2027 2028 2029 and Thereafter Future amortization expense $ 286.6 $ 73.0 $ 84.2 $ 62.4 $ 35.3 $ 13.7 $ 18.0

Debt (Tables)

Debt (Tables)	3 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Components of convertible senior notes	The following table sets forth the net carrying amount of our 2025 Notes (in millions): October 31, 2023 July 31, 2023 Principal $ 1,953.3 $ 1,999.3 Less: debt issuance costs, net of amortization (6.6) (7.8) Net carrying amount $ 1,946.7 $ 1,991.5
Interest expense recognized related to the convertible senior notes	The following table sets forth interest expense recognized related to the Notes (dollars in millions): Three Months Ended October 31, 2023 2022 2023 Notes 2025 Notes Total 2023 Notes 2025 Notes Total Contractual interest expense $ — $ 1.9 $ 1.9 $ 3.2 $ 1.8 $ 5.0 Amortization of debt issuance costs — 1.0 1.0 0.7 1.1 1.8 Total interest expense $ — $ 2.9 $ 2.9 $ 3.9 $ 2.9 $ 6.8 Effective interest rate — % 0.6 % 0.9 % 0.6 %
Warrants details	The following table presents details of our Warrants (in millions, except per share data): Initial Number of Shares Strike Price per Share Aggregate Proceeds 2023 Warrants 19.1 $ 139.27 $ 145.4 2025 Warrants 20.1 $ 136.16 $ 202.8

Commitments and Contingencies_2

Commitments and Contingencies (Tables)	3 Months Ended
	Oct. 31, 2023
Manufacturing purchase commitments
Aggregate Future Purchase Commitments
Schedule of future non-cancelable purchase commitments	The following table presents details of the aggregate future minimum or fixed purchase commitments under these arrangements, excluding obligations under contracts that we can cancel as of October 31, 2023 (in millions): Fiscal years ending July 31, Total Remaining 2024 2025 2026 2027 2028 2029 and Thereafter Manufacturing purchase commitments $ 188.2 $ 113.2 $ 35.0 $ 40.0 $ — $ — $ —
Other purchase commitments
Aggregate Future Purchase Commitments
Schedule of future non-cancelable purchase commitments	The following table presents details of the aggregate future non-cancelable purchase commitments under these agreements as of October 31, 2023 (in millions): Fiscal years ending July 31, Total Remaining 2024 2025 2026 2027 2028 2029 and Thereafter Other purchase commitments $ 1,383.3 $ 11.3 $ 387.4 $ 499.4 $ 483.8 $ 0.6 $ 0.8

Equity Award Plans (Tables)

Equity Award Plans (Tables)	3 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of RSU and PSU activities	The following table summarizes the RSU and PSU activity under our stock plans during the three months ended October 31, 2023 (in millions, except per share amounts): RSUs Outstanding PSUs Outstanding Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Number of Shares Weighted-Average Grant-Date Fair Value Per Share Aggregate Intrinsic Value Balance—July 31, 2023 12.1 $ 142.61 $ 3,013.0 5.0 $ 128.64 $ 1,242.3 Granted (1) 0.5 $ 245.46 2.1 $ 183.03 Vested (1.6) $ 123.43 (0.5) $ 145.93 Forfeited (0.4) $ 143.47 (0.4) $ 133.97 Balance—October 31, 2023 10.6 $ 150.58 $ 2,574.9 6.2 $ 145.51 $ 1,516.4 (1) For PSUs, shares granted represent the aggregate maximum number of shares that may be earned and issued with respect to these awards over their full terms.
Schedule of assumptions used and resulting grant-date fair values	The following table summarizes the assumptions used and the resulting grant-date fair value of our PSUs subject to market conditions granted during the three months ended October 31, 2023 and 2022: Three Months Ended October 31, 2023 2022 Volatility 40.8% - 43.4% 39.6% - 44.8% Expected term (in years) 0.9 - 2.9 1.0 - 4.0 Dividend yield 0.0 % 0.0 % Risk-free interest rate 4.9% - 5.3% 3.2% - 3.6% Grant-date fair value per share $346.92 - $394.63 $105.60 - $280.41
Schedule of PSO activity	The following table summarizes the PSO activity under our stock plans during the three months ended October 31, 2023 (in millions, except per share amounts): Number of Shares Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Balance—July 31, 2023 6.4 $ 65.20 2.2 $ 1,184.6 Exercised (0.1) $ 64.50 Balance—October 31, 2023 6.3 $ 65.22 1.9 $ 1,116.0 Exercisable—October 31, 2023 6.3 $ 65.22 1.9 $ 1,116.0
Schedule of allocation of share-based compensation expense	The following table summarizes share-based compensation included in costs and expenses (in millions): Three Months Ended October 31, 2023 2022 Cost of product revenue $ 2.4 $ 2.4 Cost of subscription and support revenue 30.6 28.8 Research and development 120.1 118.0 Sales and marketing 79.2 87.4 General and administrative 38.7 29.4 Total share-based compensation $ 271.0 $ 266.0

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Computation of basic and diluted net income (loss) per share of common stock	The following table presents the computation of basic and diluted net income per share of common stock (in millions, except per share data): Three Months Ended October 31, 2023 2022 Net income $ 194.2 $ 20.0 Weighted-average shares used to compute net income per share, basic 310.1 299.8 Weighted-average effect of potentially dilutive securities: Convertible senior notes 11.6 17.8 Warrants related to the issuance of convertible senior notes 16.0 7.8 Employee equity incentive plans 12.1 13.0 Weighted-average shares used to compute net income per share, diluted 349.8 338.4 Net income per share, basic $ 0.63 $ 0.07 Net income per share, diluted $ 0.56 $ 0.06
Schedule of antidilutive securities excluded from the computation of net income (loss) per share	The following securities were excluded from the computation of diluted net income per share of common stock as their effect would have been antidilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the applicable period (in millions): Three Months Ended October 31, 2023 2022 Employee equity incentive plans 2.6 2.7

Other Income (Expense), Net (Ta

Other Income (Expense), Net (Tables)	3 Months Ended
	Oct. 31, 2023
Other Income and Expenses [Abstract]
Schedule of components of other income (expense), net	The following table sets forth the components of other income, net (in millions): Three Months Ended October 31, 2023 2022 Interest income $ 71.2 $ 29.4 Foreign currency exchange gains (losses), net 5.1 4.4 Other, net (6.0) (7.8) Total other income, net $ 70.3 $ 26.0

Revenue (Disaggregation of Reve

Revenue (Disaggregation of Revenue (Geographic Theater) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue
Revenue:	$ 1,878.1	$ 1,563.4
United States
Disaggregation of Revenue
Revenue:	1,204.3	1,006.3
Other Americas
Disaggregation of Revenue
Revenue:	82.3	64.4
Total Americas
Disaggregation of Revenue
Revenue:	1,286.6	1,070.7
Europe, the Middle East, and Africa (“EMEA”)
Disaggregation of Revenue
Revenue:	364.9	307.9
Asia Pacific and Japan (“APAC”)
Disaggregation of Revenue
Revenue:	$ 226.6	$ 184.8

Revenue (Disaggregation of Re_2

Revenue (Disaggregation of Revenue (Type of Revenue) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Revenue:
Revenue:	$ 1,878.1	$ 1,563.4
Product
Revenue:
Revenue:	341.1	330
Subscription
Revenue:
Revenue:	988.3	764
Support
Revenue:
Revenue:	548.7	469.4
Subscription and support
Revenue:
Revenue:	$ 1,537	$ 1,233.4

Revenue (Deferred Revenue) (Det

Revenue (Deferred Revenue) (Details) - USD ($) $ in Billions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue recognized from opening deferred revenue balance	$ 1.4	$ 1.1

Revenue (Remaining Performance

Revenue (Remaining Performance Obligations) (Details) $ in Billions	Oct. 31, 2023 USD ($)
Remaining Performance Obligations, Expected Timing of Satisfaction
Remaining performance obligations	$ 10.4
Remaining Performance Obligations, Expected Timing of Satisfaction, Start Date: 2023-11-01
Remaining Performance Obligations, Expected Timing of Satisfaction
Remaining performance obligations	$ 5
Remaining performance obligations, expected timing of satisfaction, period	12 months

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Fair value, measurements, recurring - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	$ 1,925.8	$ 627.5
Foreign currency forward contracts	5.6	19.1
Total prepaid expenses and other current assets	5.6	19.1
Foreign currency forward contracts	0	1.7
Total other assets	0	1.7
Total assets measured at fair value	6,322.7	4,950.9
Foreign currency forward contracts	44.6	18.7
Total accrued and other liabilities	44.6	18.7
Foreign currency forward contracts	0	1.6
Total other long-term liabilities	0	1.6
Total liabilities measured at fair value	44.6	20.3
Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	1,402.4	1,254.7
Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	2,988.9	3,047.9
Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	1,595.3	476.1
Foreign currency forward contracts	0	0
Total prepaid expenses and other current assets	0	0
Foreign currency forward contracts	0	0
Total other assets	0	0
Total assets measured at fair value	1,595.3	476.1
Foreign currency forward contracts	0	0
Total accrued and other liabilities	0	0
Foreign currency forward contracts	0	0
Total other long-term liabilities	0	0
Total liabilities measured at fair value	0	0
Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Level 1 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	330.5	151.4
Foreign currency forward contracts	5.6	19.1
Total prepaid expenses and other current assets	5.6	19.1
Foreign currency forward contracts	0	1.7
Total other assets	0	1.7
Total assets measured at fair value	4,727.4	4,474.8
Foreign currency forward contracts	44.6	18.7
Total accrued and other liabilities	44.6	18.7
Foreign currency forward contracts	0	1.6
Total other long-term liabilities	0	1.6
Total liabilities measured at fair value	44.6	20.3
Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	1,402.4	1,254.7
Level 2 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	2,988.9	3,047.9
Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Foreign currency forward contracts	0	0
Total prepaid expenses and other current assets	0	0
Foreign currency forward contracts	0	0
Total other assets	0	0
Total assets measured at fair value	0	0
Foreign currency forward contracts	0	0
Total accrued and other liabilities	0	0
Foreign currency forward contracts	0	0
Total other long-term liabilities	0	0
Total liabilities measured at fair value	0	0
Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Level 3 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	1,595.3	476.1
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	1,595.3	476.1
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Certificates of deposit | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	34	48.1
Certificates of deposit | Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Certificates of deposit | Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	34	48.1
Certificates of deposit | Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	297	151.4
Commercial paper | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	136.8	213.8
Commercial paper | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Commercial paper | Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Commercial paper | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	297	151.4
Commercial paper | Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	136.8	213.8
Commercial paper | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Commercial paper | Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	8.6	0
Corporate debt securities | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	1,038.2	798
Corporate debt securities | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	2,367	2,484.3
Corporate debt securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Corporate debt securities | Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Corporate debt securities | Level 1 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Corporate debt securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	8.6	0
Corporate debt securities | Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	1,038.2	798
Corporate debt securities | Level 2 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	2,367	2,484.3
Corporate debt securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
Corporate debt securities | Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Corporate debt securities | Level 3 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	24.9	0
U.S. government and agency securities | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	148	190.6
U.S. government and agency securities | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	71.2	22
U.S. government and agency securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
U.S. government and agency securities | Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
U.S. government and agency securities | Level 1 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
U.S. government and agency securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	24.9	0
U.S. government and agency securities | Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	148	190.6
U.S. government and agency securities | Level 2 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	71.2	22
U.S. government and agency securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis
Cash equivalents	0	0
U.S. government and agency securities | Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
U.S. government and agency securities | Level 3 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Non-U.S. government and agency securities | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	33.7	0
Non-U.S. government and agency securities | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	27.9	36.6
Non-U.S. government and agency securities | Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Non-U.S. government and agency securities | Level 1 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Non-U.S. government and agency securities | Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	33.7	0
Non-U.S. government and agency securities | Level 2 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	27.9	36.6
Non-U.S. government and agency securities | Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Non-U.S. government and agency securities | Level 3 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Asset-backed securities | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	11.7	4.2
Asset-backed securities | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	522.8	505
Asset-backed securities | Level 1 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Asset-backed securities | Level 1 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Asset-backed securities | Level 2 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	11.7	4.2
Asset-backed securities | Level 2 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	522.8	505
Asset-backed securities | Level 3 | Short-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	0	0
Asset-backed securities | Level 3 | Long-Term Investments
Fair Value, Assets and Liabilities Measured on Recurring Basis
Short and long-term investments	$ 0	$ 0

Cash Equivalents and Investme_3

Cash Equivalents and Investments (Available-for-Sale Securities) (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Debt Securities, Available-for-sale
Amortized Cost	$ 4,776.5
Fair Value	4,721.8
Cash equivalents:
Debt Securities, Available-for-sale
Amortized Cost	330.5	$ 151.4
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	330.5	151.4
Cash equivalents: | Commercial paper
Debt Securities, Available-for-sale
Amortized Cost	297	151.4
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	297	151.4
Cash equivalents: | Corporate debt securities
Debt Securities, Available-for-sale
Amortized Cost	8.6
Unrealized Gains	0
Unrealized Losses	0
Fair Value	8.6
Cash equivalents: | U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost	24.9
Unrealized Gains	0
Unrealized Losses	0
Fair Value	24.9
Investments:
Debt Securities, Available-for-sale
Amortized Cost	4,446	4,339.1
Unrealized Gains	0.3	1.5
Unrealized Losses	(55)	(38)
Fair Value	4,391.3	4,302.6
Investments: | Certificates of deposit
Debt Securities, Available-for-sale
Amortized Cost	34	48.1
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	34	48.1
Investments: | Commercial paper
Debt Securities, Available-for-sale
Amortized Cost	136.9	214.1
Unrealized Gains	0	0
Unrealized Losses	(0.1)	(0.3)
Fair Value	136.8	213.8
Investments: | Corporate debt securities
Debt Securities, Available-for-sale
Amortized Cost	3,453.7	3,313.5
Unrealized Gains	0.1	1.3
Unrealized Losses	(48.6)	(32.5)
Fair Value	3,405.2	3,282.3
Investments: | U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost	219.9	214.2
Unrealized Gains	0.1	0
Unrealized Losses	(0.8)	(1.6)
Fair Value	219.2	212.6
Investments: | Non-U.S. government and agency securities
Debt Securities, Available-for-sale
Amortized Cost	62.4	37.2
Unrealized Gains	0	0
Unrealized Losses	(0.8)	(0.6)
Fair Value	61.6	36.6
Investments: | Asset-backed securities
Debt Securities, Available-for-sale
Amortized Cost	539.1	512
Unrealized Gains	0.1	0.2
Unrealized Losses	(4.7)	(3)
Fair Value	$ 534.5	$ 509.2

Cash Equivalents and Investme_4

Cash Equivalents and Investments (Available-for-sale Debt Securities Narrative) (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Gross unrealized losses for available-for-sale debt securities in a continuous unrealized loss position for less than 12 months	$ (40.4)	$ (30.7)
Available-for-sale debt securities in a continuous unrealized loss position for less than 12 months	3,300	3,400
Gross unrealized losses for available-for-sale debt securities in a continuous unrealized loss position for more than 12 months	(14.6)	(7.3)
Available-for-sale debt securities in a continuous unrealized loss position for more than 12 months	$ 922.5	$ 481.8

Cash Equivalents and Investme_5

Cash Equivalents and Investments (Available-for-Sale Securities, Contractual Maturities) (Details) $ in Millions	Oct. 31, 2023 USD ($)
Amortized Cost
Due within one year	$ 1,742.4
Due between one and three years	2,173.8
Due between three and five years	743.4
Due between five and ten years	61.3
Due after ten years	55.6
Amortized Cost	4,776.5
Fair Value
Due within one year	1,732.9
Due between one and three years	2,145.2
Due between three and five years	728.1
Due between five and ten years	60.8
Due after ten years	54.8
Fair Value	$ 4,721.8

Cash Equivalents and Investme_6

Cash Equivalents and Investments (Marketable Equity Securities) (Details) - Cash and cash equivalents - Marketable equity securities - Money market funds - USD ($)	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Jul. 31, 2023
Debt and Equity Securities, FV-NI
Carrying value	$ 1,600,000,000		$ 476,100,000
Unrealized gains or losses recognized	$ 0	$ 0

Financing Receivables (Details)

Financing Receivables (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Receivables [Abstract]
Short-term financing receivables, gross	$ 499.8	$ 435.1
Unearned income	(49.3)	(42.9)
Allowance for credit losses	(4.6)	(3.4)
Short-term financing receivables, net	445.9	388.8
Long-term financing receivables, gross	689.8	698.6
Unearned income	(42)	(39.2)
Allowance for credit losses	(8)	(6.1)
Long-term financing receivables, net	$ 639.8	$ 653.3

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Oct. 31, 2023	Jan. 31, 2023	Jul. 31, 2023
Derivative
Total notional amount	$ 777.9		$ 957.5
Unrealized losses (gains) in AOCI related to cash flow hedges	31	$ (0.7)
Losses (gains) expected to be recognized into earnings within the next 12 months	$ 29
Foreign exchange contract
Derivative
Maximum contract term of cash flow hedge	24 months

Intangible Assets (Purchased In

Intangible Assets (Purchased Intangible Assets by Major Class) (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Intangible assets subject to amortization:
Gross carrying amount	$ 830.8	$ 830.8
Total purchased intangible assets, gross carrying amount	834.7	834.7
Accumulated amortization	(544.2)	(519.3)
Total intangible assets subject to amortization, net carrying amount	286.6	311.5
Total purchased intangible assets, net carrying amount	290.5	315.4
In-process research and development
Intangible assets not subject to amortization:
In-process research and development	3.9	3.9
Developed technology
Intangible assets subject to amortization:
Gross carrying amount	633.2	633.2
Accumulated amortization	(448.5)	(429.4)
Total intangible assets subject to amortization, net carrying amount	184.7	203.8
Customer relationships
Intangible assets subject to amortization:
Gross carrying amount	172.7	172.7
Accumulated amortization	(79.3)	(73.9)
Total intangible assets subject to amortization, net carrying amount	93.4	98.8
Acquired intellectual property
Intangible assets subject to amortization:
Gross carrying amount	14.6	14.6
Accumulated amortization	(6.5)	(6.2)
Total intangible assets subject to amortization, net carrying amount	8.1	8.4
Trade name and trademarks
Intangible assets subject to amortization:
Gross carrying amount	9.4	9.4
Accumulated amortization	(9.4)	(9.4)
Total intangible assets subject to amortization, net carrying amount	0	0
Other
Intangible assets subject to amortization:
Gross carrying amount	0.9	0.9
Accumulated amortization	(0.5)	(0.4)
Total intangible assets subject to amortization, net carrying amount	$ 0.4	$ 0.5

Intangible Assets (Amortization

Intangible Assets (Amortization Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 24.9	$ 29.1

Intangible Assets (Future Amort

Intangible Assets (Future Amortization Expense of Intangible Assets) (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining 2024	$ 73
2025	84.2
2026	62.4
2027	35.3
2028	13.7
2029 and Thereafter	18
Total intangible assets subject to amortization, net carrying amount	$ 286.6	$ 311.5

Debt (Additional Details) (Deta

Debt (Additional Details) (Details) shares in Millions, $ in Millions		3 Months Ended
	Jun. 03, 2020 USD ($) day	Oct. 31, 2023 USD ($) shares	Oct. 31, 2022 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2018 USD ($)
Debt Instrument, Redemption
Repayments of Convertible Debt | $		$ 46	$ 0
2023 Notes
Debt Instrument, Redemption
Aggregate principal amount | $					$ 1,700
Contractual interest rate (in percentage)					0.75%
2025 Notes
Debt Instrument, Redemption
Aggregate principal amount | $	$ 2,000
Contractual interest rate (in percentage)	0.375%
Threshold percentage of stock price trigger (in percentage)	130%
Threshold trading days (in days)	20
Threshold consecutive trading days (in days)	30
Redemption price (in percentage)	100%
Repurchase price as percentage of principal amount in event of change (in percentage)	100%
Repayments of Convertible Debt | $		$ 46
Settlement of convertible notes (in shares) | shares		0.3
2025 Notes | Level 2
Debt Instrument, Redemption
Fair value of convertible senior notes | $		$ 4,800		$ 5,000
Option to Convert - 2025 Notes | Circumstance 1
Debt Instrument, Redemption
Threshold percentage of stock price trigger (in percentage)	130%
Threshold trading days (in days)	20
Threshold consecutive trading days (in days)	30
Option to Convert - 2025 Notes | Circumstance 2
Debt Instrument, Redemption
Threshold percentage of stock price trigger (in percentage)	98%
Threshold trading days (in days)	5
Threshold consecutive trading days (in days)	5

Debt (Details of Our Notes)

Debt (Details of Our Notes) - 2025 Notes shares in Millions	Jun. 03, 2020 shares $ / shares
Debt Instrument
Initial conversion rate (in shares per $1,000 principal amount)	10.0806
Initial conversion price (in usd per share) | $ / shares	$ 99.20
Number of common stock convertible at initial conversion rate (in shares) | shares	20.1

Debt (Components of Convertible

Debt (Components of Convertible Senior Notes) (Details) - 2025 Notes - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023
Debt Instrument, Redemption
Principal	$ 1,953.3	$ 1,999.3
Less: debt issuance costs, net of amortization	(6.6)	(7.8)
Net carrying amount	$ 1,946.7	$ 1,991.5

Debt (Schedule of Interest Expe

Debt (Schedule of Interest Expense Recognized) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Debt Instrument, Redemption
Contractual interest expense	$ 1.9	$ 5
Amortization of debt issuance costs	1	1.8
Total interest expense	2.9	6.8
2023 Notes
Debt Instrument, Redemption
Contractual interest expense	0	3.2
Amortization of debt issuance costs	0	0.7
Total interest expense	$ 0	$ 3.9
Effective interest rate	0%	0.90%
2025 Notes
Debt Instrument, Redemption
Contractual interest expense	$ 1.9	$ 1.8
Amortization of debt issuance costs	1	1.1
Total interest expense	$ 2.9	$ 2.9
Effective interest rate	0.60%	0.60%

Debt (Note Hedges) (Details)

Debt (Note Hedges) (Details) - 2025 Note Hedges - USD ($) shares in Millions, $ in Millions		3 Months Ended
	Jun. 03, 2020	Oct. 31, 2023
Schedule of Note Hedge Transactions
Initial number of shares (in shares)	20.1
Aggregate proceeds	$ 370.8
Common stock shares received from exercise of note hedges (in shares)		0.3

Debt (Warrants) (Details)

Debt (Warrants) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions			3 Months Ended
	Jun. 03, 2020	Jul. 31, 2018	Oct. 31, 2023
2023 Warrants
Class of Warrant or Right
Initial number of shares (in shares)		19.1	12.1
Strike price per share (in usd per share)		$ 139.27
Aggregate proceeds		$ 145.4
Settlement of warrants (in shares)			3.1
Settlement of warrants			$ 763.5
2025 Warrants
Class of Warrant or Right
Initial number of shares (in shares)	20.1
Strike price per share (in usd per share)	$ 136.16
Aggregate proceeds	$ 202.8

Debt (Revolving Credit Facility

Debt (Revolving Credit Facility) (Details) - Revolving credit facility - USD ($)	Apr. 13, 2023	Oct. 31, 2023
Line of Credit Facility
Current borrowing capacity	$ 400,000,000
Option for additional borrowing capacity	$ 350,000,000
Revolving credit facility amount outstanding		$ 0
Minimum
Line of Credit Facility
Commitment fee rate on undrawn amounts (in percentage)	0.09%
Maximum
Line of Credit Facility
Commitment fee rate on undrawn amounts (in percentage)	0.15%
Base Rate | Minimum
Line of Credit Facility
Spread on variable rate	0%
Base Rate | Maximum
Line of Credit Facility
Spread on variable rate	0.375%
Secured Overnight Financing Rate (SOFR) | Minimum
Line of Credit Facility
Spread on variable rate	1%
Secured Overnight Financing Rate (SOFR) | Maximum
Line of Credit Facility
Spread on variable rate	1.375%

Commitments and Contingencies_3

Commitments and Contingencies (Manufacturing Purchase Commitments) (Details) - Manufacturing purchase commitments $ in Millions	Oct. 31, 2023 USD ($)
Aggregate Future Purchase Commitments
Remaining 2024	$ 113.2
2025	35
2026	40
2027	0
2028	0
2029 and Thereafter	0
Total	$ 188.2

Commitments and Contingencies_4

Commitments and Contingencies (Other Purchase Commitments) (Details) - Other purchase commitments $ in Millions	Oct. 31, 2023 USD ($)
Aggregate Future Purchase Commitments
Remaining 2024	$ 11.3
2025	387.4
2026	499.4
2027	483.8
2028	0.6
2029 and Thereafter	0.8
Total	$ 1,383.3

Commitments and Contingencies_5

Commitments and Contingencies (Additional Information) (Details) $ in Millions	3 Months Ended
	Oct. 31, 2023 USD ($)
Service Provider
Long-Term Purchase Commitment
Minimum purchase commitment	$ 153.3

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ in Millions	Oct. 31, 2023	Aug. 31, 2022	Aug. 31, 2021	Dec. 31, 2020	Feb. 28, 2019
Equity [Abstract]
Share repurchase, authorized amount	$ 3,300	$ 915	$ 676.1	$ 700	$ 1,000
Stock repurchase, remaining authorized repurchase amount	$ 683.3

Stockholders' Equity (Schedule

Stockholders' Equity (Schedule Of Share Repurchases) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Equity [Abstract]
Number of shares repurchased (in shares)	0.3
Weighted average price per share (in dollars per share)	$ 226.67
Repurchases of common stock	$ 66.7	$ 22.7

Equity Award Plans (RSU and PSU

Equity Award Plans (RSU and PSU Activities) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2023	Jul. 31, 2023
RSUs
RSUs and PSUs, Outstanding Roll Forward
Balance, beginning (in shares)	12.1
Granted (in shares)	0.5
Vested (in shares)	(1.6)
Forfeited (in shares)	(0.4)
Balance, ending (in shares)	10.6
RSUs and PSUs, Outstanding, Weighted-Average Grant-Date Fair Value Per Share
Balance, beginning (in usd per share)	$ 142.61
Granted (in usd per share)	245.46
Vested (in usd per share)	123.43
Forfeited (in usd per share)	143.47
Balance, ending (in usd per share)	$ 150.58
RSUs and PSUs, Additional Disclosures
Aggregate intrinsic value	$ 2,574.9	$ 3,013
PSUs
RSUs and PSUs, Outstanding Roll Forward
Balance, beginning (in shares)	5
Granted (in shares)	2.1
Vested (in shares)	(0.5)
Forfeited (in shares)	(0.4)
Balance, ending (in shares)	6.2
RSUs and PSUs, Outstanding, Weighted-Average Grant-Date Fair Value Per Share
Balance, beginning (in usd per share)	$ 128.64
Granted (in usd per share)	183.03
Vested (in usd per share)	145.93
Forfeited (in usd per share)	133.97
Balance, ending (in usd per share)	$ 145.51
RSUs and PSUs, Additional Disclosures
Aggregate intrinsic value	$ 1,516.4	$ 1,242.3

Equity Award Plans (Additional

Equity Award Plans (Additional Information) (Details) - shares shares in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	0.5
RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	3 years
RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	4 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	2.1
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	1 year
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	4 years
PSUs subject to service, performance, and market conditions
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	2	1.6
Approved for future grant (in shares)	2.7
PSUs subject to service, performance, and market conditions | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Service period	1 year
PSUs subject to service, performance, and market conditions | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Service period	3 years

Equity Award Plans (Valuation A

Equity Award Plans (Valuation Assumptions) (Details) - PSUs subject to service, performance, and market conditions - $ / shares	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Volatility	40.80%	39.60%
Volatility, maximum	43.40%	44.80%
Dividend yield	0%	0%
Risk-free interest rate, minimum	4.90%	3.20%
Risk-free interest rate, maximum	5.30%	3.60%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	10 months 24 days	1 year
Grant-date fair value per share (in usd per share)	$ 346.92	$ 105.60
Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	2 years 10 months 24 days	4 years
Grant-date fair value per share (in usd per share)	$ 394.63	$ 280.41

Equity Award Plans (PSO Activit

Equity Award Plans (PSO Activities) (Details) - PSOs - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended	12 Months Ended
	Oct. 31, 2023	Jul. 31, 2023
PSOs, Outstanding Roll Forward
Balance, beginning (in shares)	6.4
Exercised (in shares)	(0.1)
Balance, ending (in shares)	6.3	6.4
Options exercisable (in shares)	6.3
PSOs, Outstanding, Weighted-Average Exercise Price Roll Forward
Balance, beginning (in usd per share)	$ 65.20
Exercised (in usd per share)	64.50
Balance, ending (in usd per share)	65.22	$ 65.20
Options exercisable, weighted-average exercise price (in usd per share)	$ 65.22
PSOs, Additional Disclosures
Weighted-average remaining contractual life (in years)	1 year 10 months 24 days	2 years 2 months 12 days
Options exercisable, weighted-average remaining contractual term (in years)	1 year 10 months 24 days
Aggregate intrinsic value	$ 1,116	$ 1,184.6
Options exercisable, aggregate intrinsic value	$ 1,116

Equity Award Plans (Allocation

Equity Award Plans (Allocation of Share-Based Compensation Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	$ 271	$ 266
Cost of revenue | Product
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	2.4	2.4
Cost of revenue | Subscription and support
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	30.6	28.8
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	120.1	118
Sales and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	79.2	87.4
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense	$ 38.7	$ 29.4

Equity Award Plans (Allocatio_2

Equity Award Plans (Allocation of Share-based Compensation, Additional Information) (Details) $ in Billions	3 Months Ended
	Oct. 31, 2023 USD ($)
Share-Based Payment Arrangement [Abstract]
Unvested share-based awards not yet recognized	$ 1.9
Weighted-average recognition period	2 years 8 months 12 days

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate (in percentage)	31.30%	41.90%

Net Income (Loss) Per Share (Co

Net Income (Loss) Per Share (Computation of Basic and Diluted Net Loss Per Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Earnings Per Share [Abstract]
Net income	$ 194.2	$ 20
Weighted-average shares used to compute net income (loss) per share, basic (in shares)	310.1	299.8
Weighted-average effect of potentially dilutive securities
Convertible senior notes (in shares)	11.6	17.8
Warrants related to the issuance of convertible senior notes (in shares)	16	7.8
Employee equity incentive plans (in shares)	12.1	13
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)	349.8	338.4
Net income (loss) per share, basic (in usd per share)	$ 0.63	$ 0.07
Net income (loss) per share, diluted (in usd per share)	$ 0.56	$ 0.06

Net Income (Loss) Per Share (Sc

Net Income (Loss) Per Share (Schedule of Antidilutive Securities Excluded from Computation) (Details) - shares shares in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Employee equity incentive plans
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	2.6	2.7

Other Income (Expense), Net (De

Other Income (Expense), Net (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Other Income and Expenses [Abstract]
Interest income	$ 71.2	$ 29.4
Foreign currency exchange gains (losses), net	5.1	4.4
Other, net	(6)	(7.8)
Total other income, net	$ 70.3	$ 26

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	Nov. 16, 2023	Nov. 06, 2023	Oct. 29, 2023	Oct. 31, 2023	Aug. 31, 2022	Aug. 31, 2021	Dec. 31, 2020	Feb. 28, 2019
Subsequent Event
Share repurchase, authorized amount				$ 3,300	$ 915	$ 676.1	$ 700	$ 1,000
Subsequent Event
Subsequent Event
Stock repurchase program, increase in authorized amount	$ 316.7
Share repurchase, authorized amount	$ 1,000
Dig Security Solutions Ltd
Subsequent Event
Total purchase consideration			$ 295
Cash			232
Fair value of replacement awards			$ 63
Talon Cyber Security Ltd | Subsequent Event
Subsequent Event
Total purchase consideration		$ 550
Cash		434.9
Fair value of replacement awards		$ 115.1